Vardenafil API is a pharmaceutical-grade Phosphodiesterase Type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) in adult men. It works by selectively inhibiting the PDE5 enzyme, increasing cyclic guanosine monophosphate (cGMP) levels in the corpus cavernosum during sexual stimulation. This enhances smooth muscle relaxation and improves blood flow to the penile tissue, facilitating and maintaining an erection.
Vardenafil is recognized for its rapid onset of action, high selectivity for the PDE5 enzyme, and proven clinical efficacy. It is widely formulated into film-coated tablets, orally disintegrating tablets (ODTs), and other oral dosage forms for the management of erectile dysfunction.
Manufactured under WHO-GMP-certified facilities, our Vardenafil API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes comprehensive analytical testing and is supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and complete regulatory documentation.